Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HUHN D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 171 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wittig, B; Marten, A; Dorbic, T; Weineck, S; Min, H; Niemitz, S; Trojaneck, B; Flieger, D; Kruopis, S; Albers, A; Loffel, J; Neubauer, A; Albers, P; Muller, S; Sauerbruch, T; Bieber, T; Huhn, D; Schmidt-Wolf, IGH
      Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: A first clinical phase I/II trial

      HUMAN GENE THERAPY
    2. Kingreen, D; Beyer, J; Kleiner, S; Reif, S; Huhn, D; Siegert, W
      ICE - an efficient drug combination for stem cell mobilization and high-dose treatment of malignant lymphoma

      EUROPEAN JOURNAL OF HAEMATOLOGY
    3. Serke, S; Schwaner, I; Yordanova, M; Szczepek, A; Huhn, D
      Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: Evidence from phenotyping after rituxan therapy and transfectant cellanalyses

      CYTOMETRY
    4. Huhn, D; von Schilling, C; Wilhelm, M; Ho, AD; Hallek, M; Kuse, R; Knauf, W; Riedel, U; Hinke, A; Srock, S; Serke, S; Peschel, C; Emmerich, B
      Rituximab therapy of patients with B-cell chronic lymphocytic leukemia

      BLOOD
    5. Marten, A; Schottker, B; Ziske, C; Weineck, S; Buttgereit, P; Huhn, D; Sauerbruch, T; Schmidt-Wolf, IGH
      Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 protein

      JOURNAL OF IMMUNOTHERAPY
    6. Lefterova, P; Marten, A; Buttgereit, P; Weineck, S; Scheffold, C; Huhn, D; Schmidt-Wolf, IGH
      Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity

      JOURNAL OF IMMUNOTHERAPY
    7. Trojaneck, B; Niemitz, S; Micka, B; Lefterova, P; Blasczyk, R; Scheffold, C; Huhn, D; Schmidt-Wolf, IGH
      Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    8. Hildebrandt, M; Rick, O; Salama, A; Siegert, W; Huhn, D; Beyer, J
      Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: Impact on clinical outcome

      CLINICAL CANCER RESEARCH
    9. Zoll, B; Lefterova, P; Ebert, O; Huhn, D; Von Ruecker, A; Schmidt-Wolf, IGH
      Modulation of cell surface markers on NK-like T lymphocytes by using IL-2,IL-7 or IL-12 in vitro stimulation

      CYTOKINE
    10. Micka, B; Trojaneck, B; Niemitz, S; Lefterova, P; Kruopis, S; Huhn, D; Wittig, B; Schadendorf, D; Schmidt-Wolf, IGH
      Comparison of non-viral transfection methods in melanoma cell primary cultures

      CYTOKINE
    11. Oettle, H; Arnold, D; Esser, M; Huhn, D; Riess, H
      Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma

      ANTI-CANCER DRUGS
    12. Schneider, U; Ruhnke, M; Delecluse, HJ; Stein, H; Huhn, D
      Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet

      ANNALS OF HEMATOLOGY
    13. Rick, O; Beyer, J; Kingreen, D; Kuhl, JS; Zingsem, J; Huhn, D; Siegert, W; Schwella, N
      Successful autologous bone marrow rescue in patients who failed peripheralblood stem cell mobilization

      ANNALS OF HEMATOLOGY
    14. Buttgereit, P; Weineck, S; Ropke, G; Marten, A; Brand, K; Heinicke, T; Caselmann, WH; Huhn, D; Schmidt-Wolf, IGH
      Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection

      CANCER GENE THERAPY
    15. Ropke, G; Ebert, O; Marten, A; Lefterova, P; Micka, B; Buttgereit, P; Niemitz, S; Trojaneck, E; Schmidt-Wolf, G; von Rucker, A; Huhn, D; Wittig, B; Schmidt-Wolf, IGH
      Increase in proliferation rate and normalization of TNF-alpha secretion byblockage of gene transfer-induced apoptosis in lymphocytes using low-dose cyclosporine A

      CANCER GENE THERAPY
    16. Oettle, H; Arning, M; Pelzer, U; Arnold, D; Stroszczynski, C; Langrehr, J; Reitzig, P; Kindler, M; Herrenberger, J; Musch, R; Korsten, FW; Huhn, D; Riess, H
      A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer

      ANNALS OF ONCOLOGY
    17. Lefterova, P; Schakowski, F; Buttgereit, P; Scheffold, C; Huhn, D; Schmidt-Wolf, IGH
      Expansion of CD3(+)CD56(+) cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy

      HAEMATOLOGICA
    18. Herold, M; Strohl, J; Assmann, M; Eschenburg, H; Franke, A; Freund, M; von Grunhagen, U; Hahnfeld, S; Hoffmann, FA; Huhn, D; Klinkenstein, C; Knauf, W; Pasold, R; Hurtz, HJ; Steglich, J; Wolf, H
      Acute toxicity of mitoxantrone, chlorambucil and prednisolone (MCP) versusMCP plus rituximab in low-grade non-Hodgkin's lymphoma - Interim results of a phase III trial

      ONKOLOGIE
    19. Serke, S; van Lessen, A; Hummel, M; Szczepek, A; Huhn, D; Stein, H
      Circulating CD4+T lymphocytes with intracellular but no surface CD3 antigen in live of seven patients consecutively diagnosed with angioimmunoblasticT-cell lymphoma

      CYTOMETRY
    20. Oertel, J; Huhn, D
      Immunocytochemical methods in haematology and oncology

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    21. Schmidt, CA; Oettle, H; Peng, R; Binder, T; Wilborn, F; Huhn, D; Siegert, W; Herbst, H
      Presence of human beta- and gamma-herpes virus DNA in Hodgkin's disease

      LEUKEMIA RESEARCH
    22. Kreuzer, KA; Lass, U; Nagel, S; Ellerbrok, H; Pauli, G; Pawlaczyk-Peter, B; Siegert, W; Huhn, D; Schmidt, CA
      Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patients

      INTERNATIONAL JOURNAL OF CANCER
    23. Zeiler, T; Wittmannn, G; Zimmermann, R; Hintz, G; Huhn, D; Riess, H
      The effect of virus inactivation on coagulation factors in therapeutic plasma

      BRITISH JOURNAL OF HAEMATOLOGY
    24. Scheffold, C; Schottker, B; Lefterova, P; Csipai, M; Glasmacher, A; Huhn, D; Neubauer, A; Schmidt-Wolf, IGH
      Increased sensitivity of myeloid leukemia cell lines: Potential of lovastatin as bone-marrow-purging agent

      ACTA HAEMATOLOGICA
    25. Ebert, O; Ropke, G; Marten, A; Lefterova, P; Micka, B; Buttgereit, P; Niemitz, S; Trojaneck, B; Schmidt-Wolf, G; Huhn, D; Wittig, B; Schmidt-Wolf, IGH
      TNF-alpha secretion and apoptosis of lymphocytes mediated by gene transfer

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    26. Oettle, H; Pelzer, U; Hochmuth, K; Diebold, T; Langrehr, J; Schmidt, CA; Arning, M; Vogl, TJ; Neuhaus, P; Huhn, D; Riess, H
      Phase I trial of gemcitabine (Gemzar (R), 24 h infusion 5-fluorouracil andfolinic acid in patients with inoperable pancreatic cancer

      ANTI-CANCER DRUGS
    27. Serke, S; Huhn, D; Johnsen, HE; Herrmann, R
      Detrimental effects of prechemotherapy filgrastim

      JOURNAL OF CLINICAL ONCOLOGY
    28. Marafioti, T; Hummel, M; Anagnostopoulos, I; Foss, HD; Huhn, D; Stein, H
      Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell

      JOURNAL OF CLINICAL ONCOLOGY
    29. Kreuzer, KA; Lass, U; Landt, O; Nitsche, A; Laser, J; Ellerbrok, H; Pauli, G; Huhn, D; Schmidt, CA
      Highly sensitive and specific fluorescence reverse transcription PCR assayfor the pseudogene-free detection of beta-actin transcripts as quantitative reference

      CLINICAL CHEMISTRY
    30. Lindauer, M; Domkin, D; Dohner, H; Kolb, HJ; Neubauer, A; Huhn, D; Kreiter, H; Koch, B; Huber, C; Aulitzky, W; Fischer, T
      Efficacy and toxicity of IFN-alpha 2b combined with cytarabine in chronic myelogenous leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    31. Schmidt-Wolf, IGH; Finke, S; Trojaneck, B; Denkena, A; Lefterova, P; Schwella, N; Heuft, HG; Prange, G; Korte, M; Takeya, M; Dorbic, T; Neubauer, A; Wittig, B; Huhn, D
      Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma

      BRITISH JOURNAL OF CANCER
    32. Serke, S; Riess, H; Oettle, H; Huhn, D
      Elevated reticulocyte count - a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report

      BRITISH JOURNAL OF CANCER
    33. Baurmann, H; Thiede, C; Nagel, S; Binder, T; Neubauer, A; Siegert, W; Huhn, D
      Chimerism following donor lymphocyte infusion for chronic myeloid leukemia- Response

      BLOOD
    34. SERKE S; VANLESSEN A; PARDO I; HUHN D
      SELECTIVE SUSCEPTIBILITY OF CD34-EXPRESSING CELLS TO ACQUIRE FLOW CYTOMETRIC FEATURES OF APOPTOSIS NECROSIS ON EXPOSURE TO AN AMMONIUM CHLORIDE-BASED RED-BLOOD-CELL LYSING REAGENT/

      Journal of hematotherapy
    35. SERKE S; HUHN D
      CIRCULATING CD34-EXPRESSING CELLS - GERMAN PROFICIENCY TESTING SURVEY

      Journal of hematotherapy
    36. WEISS R; HUHN D; MITROU P; NERL C; SCHURMANN D; SCHEIDEGGER C; KNAUF W; TRENN G; KRONAWITTER U; VANLUNZEN J; ARASTEH K; HERBST H
      HIV-RELATED NON-HODGKINS-LYMPHOMA - CHOP INDUCTION THERAPY AND INTERFERON-ALPHA-2B ZIDOVUDINE MAINTENANCE THERAPY/

      Leukemia & lymphoma
    37. Muller, M; Scheffold, C; Lefterova, P; Huhn, D; Neubauer, A; Schmidt-Wolf, IGH
      Potential of autologous immunologic effector cells for prediction of progression of disease in patients with chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    38. FINKE S; TROJANECK B; LEFTEROVA P; CSIPAI M; WAGNER E; KIRCHEIS R; NEUBAUER A; HUHN D; WITTIG B; SCHMIDTWOLF IGH
      INCREASE OF PROLIFERATION RATE AND ENHANCEMENT OF ANTITUMOR CYTOTOXICITY OF EXPANDED HUMAN CD3(-CELLS BY RECEPTOR-MEDIATED TRANSFECTION WITH THE INTERLEUKIN-7 GENE()CD56(+) IMMUNOLOGICAL EFFECTOR)

      Gene therapy
    39. Rick, O; Beyer, J; Kingreen, D; Schwella, N; Krusch, A; Schleicher, J; Kirsch, A; Huhn, D; Siegert, W
      High-dose chemotherapy in germ cell tumours: a large single centre experience

      EUROPEAN JOURNAL OF CANCER
    40. FISCHER T; NEUBAUER A; MOHM J; HUHN D; BUSEMANN C; LINK H; ARSENIEV L; BUSSING B; NOVOTNY J; GANSER A; DUYSTER J; BUNJES D; WESTERMEIER T; FLOHR T; DESPRES D; GAMM H; DECKER J; DERIGS G; AULITZKY W; HUBER C
      OUTCOME OF PERIPHERAL-BLOOD STEM-CELL MOBILIZATION IN ADVANCED PHASESOF CML IS DEPENDENT ON THE TYPE OF CHEMOTHERAPY APPLIED

      Annals of hematology
    41. OERTEL S; JONAS S; HUMMEL M; HETZER R; HUHN D; NEUHAUS P; RIESS H
      THERAPEUTIC MANAGEMENT AND RESULTS OF 21 PATIENTS WITH POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS

      Annals of oncology
    42. LUNDIN J; OSTERBORG A; BRITTINGER G; CROWTHER D; DOMBRET H; ENGERT A; EPENETOS A; GISSELBRECHT C; HUHN D; JAEGER U; THOMAS J; MARCUS R; NISSEN N; POYNTON C; RANKIN E; STAHEL R; UPPENKAMP M; WILLEMZE R; MELLSTEDT H
      CAMPATH-1H MONOCLONAL-ANTIBODY IN THERAPY FOR PREVIOUSLY TREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II MULTICENTER STUDY

      Journal of clinical oncology
    43. Zoll, B; Lefterova, P; Csipai, M; Finke, S; Trojaneck, B; Ebert, O; Micka, B; Roigk, K; Fehlinger, M; Schmidt-Wolf, GD; Huhn, D; Schmidt-Wolf, IGH
      Generation of cytokine-induced killer cells using exogenous in interleukin-2, -7 or -12

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    44. HILDEBRANDT M; BLASER F; BEYER J; SIEGERT W; MAPARA MY; HUHN D; SALAMA A
      DETECTION OF TUMOR-CELLS IN PERIPHERAL-BLOOD SAMPLES FROM PATIENTS WITH GERM-CELL TUMORS USING IMMUNOCYTOCHEMICAL AND REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION TECHNIQUES

      Bone marrow transplantation
    45. SIEGERT W; BEYER J; KINGREEN D; BLASCZYK R; BAURMANN H; SCHWELLA N; SCHLEICHER J; KIRSCH A; HUHN D
      TREATMENT OF RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH UNMANIPULATED G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELL PREPARATION

      Bone marrow transplantation
    46. SIEGERT W; RICK O; BEYER J; SCHWELLA N; SCHLEICHER J; HUHN D
      CURRENT TREATMENT RESULTS AND FUTURE INDICATIONS FOR HIGH-DOSE CHEMOTHERAPY IN GERM-CELL TUMORS

      Bone marrow transplantation
    47. SCHWELLA N; RICK O; MEYER O; LOFFEL J; SCHLEICHER J; SERKE S; HUHN D; RIESS H
      MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS BY DISEASE-SPECIFICCHEMOTHERAPY IN PATIENTS WITH SOFT-TISSUE SARCOMA

      Bone marrow transplantation
    48. FISCHER T; NEUBAUER A; MOHM J; HUHN D; BUSEMANN C; LINK H; ARSENIEV L; BUSSING B; NOVOTNY J; GANSER A; DUYSTER J; BUNJES D; KREITER S; AULITZKY W; HEHLMANN R; HUBER C
      CHEMOTHERAPY-INDUCED MOBILIZATION OF KARYOTYPICALLY NORMAL PBSC FOR AUTOGRAFTING IN CML

      Bone marrow transplantation
    49. GOLDSCHMIDT H; MARTIN H; HEGENBART U; KO Y; GLASMACHER A; GERHARTZ H; HANEL A; RUDOLPH C; WILHELM M; GIESELER F; BORNHAUSER M; EHNINGER G; HOELZER D; HUHN D; HAAS R
      TANDEM AUTOLOGOUS TRANSPLANTATION (TPX) FOR MULTIPLE-MYELOMA - FIRST RESULTS OF A GERMAN MULTICENTER STUDY

      Bone marrow transplantation
    50. RICK O; BEYER J; SCHWELLA N; KINGREEN D; KIRSCH A; SCHLEICHER J; KRUSCH A; HUHN D; SIEGERT W
      LONG-TERM SURVIVAL AFTER HIGH-DOSE SALVAGE CHEMOTHERAPY IN PATIENTS WITH GERM-CELL TUMORS

      Bone marrow transplantation
    51. SERKE S; VANLESSEN A; HUHN D
      QUANTITATIVE FLUORESCENCE FLOW-CYTOMETRY - A COMPARISON OF THE 3 TECHNIQUES FOR DIRECT AND INDIRECT IMMUNOFLUORESCENCE

      Cytometry
    52. HEUFT HG; BERG T; SCHREIER E; KUNKEL U; TACKE M; SCHWELLA N; HOPF U; SALAMA A; HUHN D
      EPIDEMIOLOGIC AND CLINICAL ASPECTS OF HEPATITIS-G VIRUS-INFECTION IN BLOOD-DONORS AND IMMUNOCOMPROMISED RECIPIENTS OF HGV-CONTAMINATED BLOOD

      Vox sanguinis
    53. SCHWELLA N; RICK O; HEUFT HG; MIKSITS K; ZIMMERMANN R; ZINGSEM J; ECKSTEIN R; HUHN D
      BACTERIAL-CONTAMINATION OF AUTOLOGOUS BONE-MARROW - REINFUSION OF CULTURE-POSITIVE GRAFTS DOES NOT RESULT IN CLINICAL SEQUELAE DURING THE POSTTRANSPLANTATION COURSE

      Vox sanguinis
    54. SERKE S; BEYER J; RICK O; SCHWELLA N; MEYER O; HILDEBRANDT M; HUHN D
      ANALYSIS OF CD34-EXPRESSING CELLS IN CLINICAL-PRACTICE

      Vox sanguinis
    55. Oertel, J; Oertel, B; Schleicher, J; Huhn, D
      Detection of small numbers of immature cells in the blood of healthy subjects

      JOURNAL OF CLINICAL PATHOLOGY
    56. OERTEL S; ANAGNOSTOPOULOS I; HUMMEL M; JONAS S; STEIN H; NEUHAUS P; HETZER R; HUHN D; RIESS H
      CLINICOPATHOLOGICAL CHARACTERISTICS OF 21 PATIENTS WITH POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS (PT-LPD)

      British Journal of Haematology
    57. GOLDSCHMIDT H; MARTIN H; SERKE S; HEGENBART U; GLASMACHER A; KO Y; SCHULTZE W; HANEL A; RUDOLPH C; GERHARTZ H; HASTKA J; WILHELM M; GIESELER F; BORNHAUSER M; EHNINGER G; HOELZER D; HUHN D; HAAS R
      TANDEM AUTOLOGOUS TRANSPLANTATION (TPX) FOR MULTIPLE-MYELOMA - RESULTS OF A GERMAN MULTICENTER STUDY

      British Journal of Haematology
    58. BAURMANN H; NAGEL S; BINDER T; NEUBAUER A; SIEGERT V; HUHN D
      KINETICS OF THE GRAFT-VERSUS-LEUKEMIA RESPONSE AFTER DONOR LEUKOCYTE INFUSIONS FOR RELAPSED CHRONIC MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    59. HELD TK; MIELKE MEA; CHEDID M; UNGER M; TRAUTMANN M; HUHN D; CROSS AS
      GRANULOCYTE-COLONY-STIMULATING FACTOR WORSENS THE OUTCOME OF EXPERIMENTAL KLEBSIELLA-PNEUMONIAE PNEUMONIA THROUGH DIRECT INTERACTION WITH THE BACTERIA

      Blood
    60. SCHMIDT M; NAGEL S; PROBA J; THIEDE C; RITTER M; WARING JF; ROSENBAUER F; HUHN D; WITTIG B; HORAK I; NEUBAUER A
      LACK OF INTERFERON CONSENSUS SEQUENCE BINDING-PROTEIN (ICSBP) TRANSCRIPTS IN HUMAN MYELOID LEUKEMIAS

      Blood
    61. WEISS R; HUHN D; MITROU P; NERL C; SHURMANN D; SCHEIDEGGER C; KNAUF W; TRENN G; KRONAWITTER U; VANLUNZEN J; ARASTEH K; HERBST H
      HIV-RELATED NON-HODGKINS-LYMPHOMA - CHOP INDUCTION THERAPY AND INTERFERON-A-2B ZIDOVUDINE MAINTENANCE THERAPY/

      Journal of acquired immune deficiency syndromes and human retrovirology
    62. SCHNEIDER U; RUHNKE M; DELECLUSE HJ; HUHN D
      TREATMENT OF EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS IN HIV-INFECTED PATIENTS WITH FOSCARNET

      Journal of acquired immune deficiency syndromes and human retrovirology
    63. NEUBAUER A; BURCHERT A; MAIWALD C; GRUSS HJ; SERKE S; HUHN D; WITTIG B; LIU E
      RECENT PROGRESS ON THE ROLE OF AXL, A RECEPTOR TYROSINE KINASE, IN MALIGNANT TRANSFORMATION OF MYELOID LEUKEMIAS

      Leukemia & lymphoma
    64. EBERT O; FINKE S; SALAHI A; HERRMANN M; TROJANECK B; LEFTEROVA P; WAGNER E; KIRCHEIS R; HUHN D; SCHRIEVER F; SCHMIDTWOLF IGH
      LYMPHOCYTE APOPTOSIS - INDUCTION BY GENE-TRANSFER TECHNIQUES

      Gene therapy
    65. HEIDE I; THIEDE C; SONNTAG T; DEKANT E; NEUBAUER A; JONAS S; PETER FJ; NEUHAUS P; HERRMANN R; HUHN D; ROCHLITZ CF
      THE STATUS OF P53 IN THE METASTATIC PROGRESSION OF COLORECTAL-CANCER

      European journal of cancer
    66. RICK O; BEYER J; SCHWELLA N; KINGREEN D; KRUSCH A; HUHN D; SIEGERT W
      LONG-TERM SURVIVAL AND LATE TOXICITIES AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS SUFFERING FROM GERM-CELL CANCER

      European journal of cancer
    67. FINKE S; TROJANECK B; MOLLER P; SCHADENDORF D; NEUBAUER A; HUHN D; SCHMIDTWOLF IGH
      INCREASE OF CYTOTOXIC SENSITIVITY OF PRIMARY HUMAN-MELANOMA CELLS TRANSFECTED WITH THE INTERLEUKIN-7 GENE TO AUTOLOGOUS AND ALLOGENEIC IMMUNOLOGICAL EFFECTOR-CELLS

      Cancer gene therapy
    68. RICK O; HEUFT HG; WITTMANN G; BLASCZYK R; HUHN D; SCHWELLA N
      PREPARATION OF AUTOLOGOUS BONE-MARROW GRAFTS FOR CRYOPRESERVATION USING THE AS104 CELL SEPARATOR

      Journal of clinical apheresis
    69. OSTERBORG A; DYER MJS; BUNJES D; PANGALIS GA; BASTION Y; CATOVSKY D; MELLSTEDT H; RANKIN E; TSEKOURAS C; PANGALIS GA; CAVALLI F; SESSA C; HUHN D; MARCUS R; MAUGHAN T; POYNTON C; NISSEN N; CARNEY D; BRITTINGER G; UPPENKAMP M; ELONEN E; TEERENHOVI L; ENGERT; WILLEMZE R; KLUINNELEMANS J; THOMAS J; EPENETOS AA; NETHERSELL A; DYER M; CATOVSKY D; DICATO M; BASTION Y; COIFFIER B; RANADA JMF; CROWTHER D; WOLL P; RAEMAKAERS J; DEPAUW B; DEGOS L; GISSELLBRECHT; REIFFERS J; MELLSTEDT H; FASSAS A; ANAGNOSTOPOULOS A; BUNJES D; JAEGER U; STAHEL RA
      PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA

      Journal of clinical oncology
    70. KLEINER S; KIRSCH A; SCHWANER I; KINGREEN D; SCHWELLA N; HUHN D; SIEGERT W
      HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE IN PATIENTS WITH RELAPSED OR REFRACTORY MALIGNANT-LYMPHOMAS - A PHASE I II STUDY/

      Bone marrow transplantation
    71. SERKE S; ARSENIEV L; WATTS M; FRITSCH G; INGLESESTEVE J; JOHNSEN HE; LINCH D; CANCELAS JA; MEYER O; KADAR JG; HUHN D; MATCHAM J
      IMPRECISION OF COUNTING CFU-GM COLONIES AND CD34-EXPRESSING CELLS

      Bone marrow transplantation
    72. SCHWELLA N; KINGREEN D; HEUFT HG; OETTLE H; RICK O; SERKE S; HUHN D; SIEGERT W
      PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTION DURING HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS BLOOD PROGENITOR-CELL TRANSPLANTATION

      Vox sanguinis
    73. ESCHRICH S; ZOUBOULIS CC; SCHWEIGER U; RIESS H; HUHN D
      PELVIC PHLEBOTHROMBOSIS DESPITE ANTICOAGU LANT-THERAPY IN A 17-YEAR-OLD PATIENT - ADAMANTIADES-BEHCET DISEASE WITH VASCULAR INVOLVEMENT

      Der Internist
    74. BEYER J; KINGREEN D; KRAUSE M; SCHLEICHER J; SCHWANER I; SCHWELLA N; HUHN D; SIEGERT W
      LONG-TERM SURVIVAL OF PATIENTS WITH RECURRENT OR REFRACTORY GERM-CELLTUMORS AFTER HIGH-DOSE CHEMOTHERAPY

      Cancer
    75. MEYER O; STAHL D; BECKHOVE P; HUHN D; SALAMA A
      PULSED HIGH-DOSE DEXAMETHASONE IN CHRONIC AUTOIMMUNE HEMOLYTIC-ANEMIAOF WARM TYPE

      British Journal of Haematology
    76. SCHNEIDER U; VANLESSEN A; HUHN D; SERKE S
      2 SUBSETS OF PERIPHERAL-BLOOD PLASMA-CELLS DEFINED BY DIFFERENTIAL EXPRESSION OF CD45 ANTIGEN

      British Journal of Haematology
    77. SCHMIDT M; NAGEL S; PROBA J; HOCHHAUS A; WARING JF; ROSENBAUER F; EHNINGER G; HUHN D; WITTIG B; HEHLMANN R; HORAK I; NEUBAUER A
      LACK OF INTERFERON CONSENSUS SEQUENCE BINDING-PROTEIN (ICSBP) TRANSCRIPTS IN HUMAN MYELOID LEUKEMIAS AND INDUCTION BY INTERFERON-ALPHA

      Blood
    78. GERHARTZ HH; SCHWENKE H; BAZARBASHI S; THIEL E; BLAU W; HUHN D; HEIMPEL H; BROWN P; SCHLIEMOK G; ILLIGER HJ; WALTHER J; WILMANNS W; CHARISSE G; FARBER L; HAUS U
      RANDOMIZED COMPARISON OF COPP ABVD VS. DOSE-ESCALATED AND TIME-ESCALATED COPP/ABVD WITH GM-CSF SUPPORT FOR ADVANCED HODGKINS-DISEASE/

      Blood
    79. ENGELHARD M; BRITTINGER G; HUHN D; GERHARTZ HH; MEUSERS P; SIEGERT W; THIEL E; WILMANNS W; AYDEMIR U; BIERWOLF S; GRIESSER H; TIEMANN M; LENNERT K
      SUBCLASSIFICATION OF DIFFUSE LARGE B-CELL LYMPHOMAS ACCORDING TO THE KIEL CLASSIFICATION - DISTINCTION OF CENTROBLASTIC AND IMMUNOBLASTIC LYMPHOMAS IS A SIGNIFICANT PROGNOSTIC RISK FACTOR

      Blood
    80. DELECLUSE HJ; ANAGNOSTOPOULOS I; DALLENBACH F; HUMMEL M; MARAFIOTI T; SCHNEIDER U; HUHN D; SCHMIDTWESTHAUSEN A; REICHART PA; GROSS U; STEIN H
      PLASMABLASTIC LYMPHOMAS OF THE ORAL CAVITY - A NEW ENTITY ASSOCIATED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Blood
    81. BINDER T; WEHLING J; HUHN D; BLASCZYK R
      INCREASED DIVERSITY WITHIN THE HLA-A-ASTERISK-66 GROUP - IMPLICATIONSFOR MATCHING IN UNRELATED BONE-MARROW TRANSPLANTATION

      Tissue antigens
    82. BERG T; SCHREIER E; HEUFT HG; NAUMANN U; NEUHAUS P; HUHN D; HOPF U
      HEPATITIS-G-VIRUS INFECTION - EPIDEMIOLOG IC ASPECTS AND CLINICAL RELEVANCE

      Deutsche Medizinische Wochenschrift
    83. CSIPAI M; LEFTEROVA P; FINKE S; JOHNSTON V; SCHEFFOLD C; HUHN D; SCHMIDTWOLF IGH
      EFFECTS OF HUMAN INTERLEUKIN-7 ON PROLIFERATION OF TUMOR AND IMMUNOLOGICAL EFFECTOR-CELLS

      Cancer research, therapy & control
    84. OERTEL J; OERTEL B; SCHLEICHER J; HUHN D
      IMMUNOTYPING OF BLASTS IN HUMAN BONE-MARROW

      Annals of hematology
    85. SELIGER B; PAPADILERIS S; VOGEL D; HESS G; BRENDEL C; STORKEL S; ORTEL J; KOLBE K; HUBER C; HUHN D; NEUBAUER A
      ANALYSIS OF THE P53 AND MDM-2 GENE IN ACUTE MYELOID-LEUKEMIA

      European journal of haematology
    86. NEUBAUER A; THIEDE C; HUHN D; WITTIG B
      P53 AND INDUCTION OF APOPTOSIS AS A TARGET FOR ANTICANCER THERAPY

      Leukemia
    87. SCHWELLA N; BEYER J; SCHWANER I; HEUFT HG; RICK O; HUHN D; SERKE S; SIEGERT W
      IMPACT OF PRELEUKAPHERESIS CELL COUNTS ON COLLECTION RESULTS AND CORRELATION OF PROGENITOR-CELL DOSE WITH ENGRAFTMENT AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH GERM-CELL CANCER

      Journal of clinical oncology
    88. NAGEL S; SCHMIDT M; THIEDE C; HUHN D; NEUBAUER A
      QUANTIFICATION OF BCR-ABL TRANSCRIPTS IN CHRONIC MYELOGENOUS LEUKEMIA(CML) USING STANDARDIZED, INTERNALLY CONTROLLED, COMPETITIVE DIFFERENTIAL PCR (CD-PCR)

      Nucleic acids research
    89. HUHN D; WEISS R; MITROU P; NERL C; SCHURMANN D; SCHEIDEGGER C; KNAUF W; TRENN G; KRONAWITTER U; VANLUNZEN J; HERBST H
      CLINICAL-RESULTS AND IMMUNE PARAMETERS AFTER TREATMENT WITH CYTOSTATICS AND INTERFERON-ALPHA (IFN-ALPHA) IN HIV-RELATED NON-HODGKINS-LYMPHOMAS (HIV-NHL)

      Experimental hematology
    90. AULITZKY WE; NEUBAUER A; KOLBE K; SCHNELLER F; BUSEMANN C; SCHLEIERMACHER E; PESCHEL C; SIEGERT W; HUBER C; HUHN D
      PRELIMINARY-RESULTS OF STEM-CELL MOBILIZATION IN CHRONIC MYELOID-LEUKEMIA WITH A MODERATE INTENSITY CHEMOTHERAPY REGIMEN AND G-CSF OR G-CSFPLUS IL-3

      Bone marrow transplantation
    91. BLASCZYK R; WEBER M; VANLESSEN A; SCHWELLA N; HUHN D; SALAMA A
      DISCRIMINATION OF HLA-B27 ALLELES BY GROUP-SPECIFIC AMPLIFICATION FOLLOWED BY SOLID-PHASE SEQUENCING

      Human immunology
    92. SERKE S; HUHN D
      EXPRESSION OF CLASS-I, CLASS-II, AND CLASS-III EPITOPES OF THE CD34 ANTIGEN BY NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS

      Cytometry
    93. VILLAMOR N; KIRSCH A; HUHN D; VIVESCORRONS JL; SERKE S
      INTERFERENCE OF BLOOD LEUKOCYTES IN THE MEASUREMENTS OF IMMATURE RED-CELLS (RETICULOCYTES) BY 2 DIFFERENT (SEMI-)AUTOMATED FLOW-CYTOMETRY TECHNOLOGIES

      Clinical and laboratory haematology
    94. SCHWELLA N; HEUFT HG; RICK O; BLASCZYK R; WITTMANN G; HUHN D
      ANALYSIS FOR RECOVERY AND LOSS OF MONONUCLEAR-CELLS AND COLONY-FORMING-UNITS GRANULOCYTE-MACROPHAGE DURING EX-VIVO PROCESSING OF AUTOLOGOUSBONE-MARROW

      Vox sanguinis
    95. SCHMIDTWOLF IGH; LEFTEROVA P; JOHNSTON V; SCHEFFOLD C; CSIPAI M; MEHTA BA; TSURUO T; HUHN D; NEGRIN RS
      SENSITIVITY OF MULTIDRUG-RESISTANT TUMOR-CELL LINES TO IMMUNOLOGICAL EFFECTOR-CELLS

      Cellular immunology
    96. LUBBE AS; BERGEMANN C; RIESS H; SCHRIEVER F; REICHARDT P; POSSINGER K; MATTHIAS M; DORKEN B; HERRMANN F; GURTLER R; HOHENBERGER P; HAAS N; SOHR R; SANDER B; LEMKE AJ; OHLENDORF D; HUHNT W; HUHN D
      CLINICAL-EXPERIENCES WITH MAGNETIC DRAG TARGETING - A PHASE-I STUDY WITH 4'-EPIDOXORUBICIN IN 14 PATIENTS WITH ADVANCED SOLID TUMORS

      Cancer research
    97. LUBBE AS; BERGEMANN C; HUHNT W; FRICKE T; RIESS H; BROCK JW; HUHN D
      PRECLINICAL EXPERIENCES WITH MAGNETIC DRUG TARGETING - TOLERANCE AND EFFICACY

      Cancer research
    98. BUSEMANN C; AULITZKY W; NAGEL S; BAURMANN H; KREISSIG C; SALAMA A; SIEGERT W; HUHN D; HUBER C; NEUBAUER A
      MILD CHEMOTHERAPY CAN MOBILIZE PHILADELPHIA-NEGATIVE CD34-POSITIVE CELLS IN LATE CHRONIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA (CML)

      Blood
    99. BAURMANN H; SIEGERT W; HUHN D
      SEQUENTIAL-ANALYSIS OF CHIMERISM BY FLUORESCENT IN-SITU HYBRIDIZATION(FISH) FOLLOWING INFUSION OF DONOR LEUKOCYTES FOR THE TREATMENT OF RELAPSED CML AFTER ALLOGENEIC BMT

      Blood
    100. EBERT O; FINKE S; SALAHI A; HERRMANN M; TROJANECK B; LEFTEROVA P; NEUBAUER A; HUHN D; SCHRIEVER F; SCHMIDTWOLF I
      INDUCTION OF APOPTOSIS IN LYMPHOCYTES BY GENE-TRANSFER TECHNIQUES

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 12:11:50